Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:3198-3203

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doval, H. C.
Right arrow Articles by Perrone, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doval, H. C.
Right arrow Articles by Perrone, S. V.

(Circulation. 1996;94:3198-3203.)
© 1996 American Heart Association, Inc.


Articles

Nonsustained Ventricular Tachycardia in Severe Heart Failure

Independent Marker of Increased Mortality due to Sudden Death

Hernan C. Doval, MD; Daniel R. Nul, MD; Hugo O. Grancelli, MD; Sergio D. Varini, MD; Saul Soifer, MD; Gianni Corrado, MD; Sergio Dubner, MD; Omar Scapin, MD; Sergio V. Perrone, MD; for the GESICA-GEMA Investigators*

Correspondence to Dr Hernan C. Doval, Malvinas Argentinas 740, Capital Federal, Argentina, CP 1406.

Background The goal of the study was to determine the prognostic value of nonsustained ventricular tachycardia (NSVT) in total mortality in severe congestive heart failure (CHF) and in death modes. NSVT is associated with an increased mortality in CHF. However, the predictive value of NSVT as a marker for sudden death or death due to progressive heart failure has not been determined.

Methods and Results Five hundred sixteen patients from the GESICA trial (33.4% with NSVT) were initially studied with the results of 24-hour Holter and 2 years of follow-up. Within 2 years, 87 of 173 patients (50.3%) with NSVT and 106 of 343 patients (30.9%) without NSVT died. Relative risk (RR) was 1.69 (95% confidence interval [CI], 1.27 to 2.24; P<.0002), and Cox proportional hazard analysis was 1.62 (95% CI, 1.22 to 2.16; P<.001). Sudden death increased from 8.7% (30 of 343) to 23.7% (41 of 173) in patients with NSVT (RR, 2.77; 95% CI, 1.78 to 4.44; P<.001). Progressive heart failure death was also increased from 17.5% (60 of 343) to 20.8% (36 of 173) (P=.22). Quantitative analysis of 24-hour Holter (first 295 patients) demonstrated that couplets had a similar RR to that of NSVT for both total mortality (RR, 1.81; 95% CI, 1.22 to 2.66; P<.002) and sudden death (RR, 3.37; 95% CI, 1.57 to 7.25; P<.0005). Couplets and/or NSVT (ventricular repetitive beats) were even more predictive for sudden death (RR, 10.1; 95% CI, 1.91 to 52.7; P<.01).

Conclusions In patients with CHF, NSVT is an independent marker for increased overall mortality rate and sudden death. The absence of NSVT and ventricular repetitive beats in a 24-hour Holter indicates a low probability of sudden death.


Key Words: heart failure • arrhythmias • death, sudden




This article has been cited by other articles:


Home page
Eur Heart JHome page
S. Boveda, E. Marijon, S. Jacob, P. Defaye, J. B. Winter, A. Bulava, D. Gras, J. P. Albenque, N. Combes, D. Pavin, et al.
Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study
Eur. Heart J., May 2, 2009; 30(10): 1237 - 1244.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. R. de Sousa, C. A. Morillo, F. T. Rabelo, A. M. N. Filho, and A. L.P. Ribeiro
Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis
Eur J Heart Fail, October 1, 2008; 10(10): 1007 - 1014.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1179 - 1199.
[Full Text] [PDF]


Home page
CirculationHome page
J. J. Goldberger, M. E. Cain, S. H. Hohnloser, A. H. Kadish, B. P. Knight, M. S. Lauer, B. J. Maron, R. L. Page, R. S. Passman, D. Siscovick, et al.
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention
Circulation, September 30, 2008; 118(14): 1497 - 1518.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. E. Shoaf, M. V. Elizari, Z. Wang, K. Sekar, L. R. Grinfeld, N. A. Barbagelata, J. Lerman, S. L. Bramer, J. Tronge, and C. Orlandi
Tolvaptan Administration Does Not Affect Steady State Amiodarone Concentrations in Patients With Cardiac Arrhythmias
Journal of Cardiovascular Pharmacology and Therapeutics, July 1, 2005; 10(3): 165 - 171.
[Abstract] [PDF]


Home page
HeartHome page
M T Kearney, K A A Fox, A J Lee, W P Brooksby, A M Shah, A Flapan, R J Prescott, R Andrews, P D Batin, D L Eckberg, et al.
Predicting sudden death in patients with mild to moderate chronic heart failure
Heart, October 1, 2004; 90(10): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. G Katritsis and A.J. Camm
Nonsustained ventricular tachycardia: where do we stand?
Eur. Heart J., July 1, 2004; 25(13): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Kadish, A. Dyer, J. P. Daubert, R. Quigg, N.A. M. Estes, K. P. Anderson, H. Calkins, D. Hoch, J. Goldberger, A. Shalaby, et al.
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
N. Engl. J. Med., May 20, 2004; 350(21): 2151 - 2158.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Hohnloser, T. Klingenheben, D. Bloomfield, O. Dabbous, and R. J. Cohen
Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study
J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2220 - 2224.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. C. Deedwania
The Key to Unraveling the Mystery of Mortality in Heart Failure: An Integrated Approach
Circulation, April 8, 2003; 107(13): 1719 - 1721.
[Full Text] [PDF]


Home page
CirculationHome page
R. Berger, M. Huelsman, K. Strecker, A. Bojic, P. Moser, B. Stanek, and R. Pacher
B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure
Circulation, May 21, 2002; 105(20): 2392 - 2397.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. Grimm, J.u. Hoffmann, H.-H. Muller, and B. Maisch
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%
J. Am. Coll. Cardiol., March 6, 2002; 39(5): 780 - 787.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. V. Huikuri, A. Castellanos, and R. J. Myerburg
Sudden Death Due to Cardiac Arrhythmias
N. Engl. J. Med., November 15, 2001; 345(20): 1473 - 1482.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force for the Diagnosis and Treatment of Chro, W. J. Remme, and K. Swedberg
Guidelines for the diagnosis and treatment of chronic heart failure
Eur. Heart J., September 1, 2001; 22(17): 1527 - 1560.
[PDF]


Home page
J Am Coll CardiolHome page
T. M. Ramahi, M. D. Longo, A. R. Cadariu, K. Rohlfs, S. A. Carolan, K. M. Engle, H. Samady, and F. J. T. Wackers
Left ventricular inotropic reserve and right ventricular function predict increase of left ventricular ejection fraction after beta-blocker therapy in nonischemic cardiomyopathy
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 818 - 824.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Cice, E. Tagliamonte, L. Ferrara, and A. Iacono
Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study
Eur. Heart J., August 1, 2000; 21(15): 1259 - 1264.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
A. D. Auerbach, M. B. Hamel, R. B. Davis, A. F. Connors Jr., C. Regueiro, N. Desbiens, L. Goldman, R. M. Califf, N. V. Dawson, N. Wenger, et al.
Resource Use and Survival of Patients Hospitalized with Congestive Heart Failure: Differences in Care by Specialty of the Attending Physician
Ann Intern Med, February 1, 2000; 132(3): 191 - 200.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. R. Teerlink, M. Jalaluddin, S. Anderson, M. L. Kukin, E. J. Eichhorn, G. Francis, M. Packer, and B. M. Massie
Ambulatory Ventricular Arrhythmias in Patients With Heart Failure Do Not Specifically Predict an Increased Risk of Sudden Death
Circulation, January 4, 2000; 101(1): 40 - 46.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P S Macdonald, A M Keogh, C Aboyoun, M Lund, R Amor, and D McCaffrey
Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure
Heart, November 1, 1999; 82(5): 589 - 593.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al.
ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
P. J. Zimetbaum and M. E. Josephson
The Evolving Role of Ambulatory Arrhythmia Monitoring in General Clinical Practice
Ann Intern Med, May 18, 1999; 130(10): 848 - 856.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. M. Pogwizd, J. P. McKenzie, and M. E. Cain
Mechanisms Underlying Spontaneous and Induced Ventricular Arrhythmias in Patients With Idiopathic Dilated Cardiomyopathy
Circulation, December 1, 1998; 98(22): 2404 - 2414.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. P. Zipes and H. J. J. Wellens
Sudden Cardiac Death
Circulation, November 24, 1998; 98(21): 2334 - 2351.
[Full Text] [PDF]


Home page
CirculationHome page
A. N. Cheema, K. Sheu, M. Parker, A. H. Kadish, and J. J. Goldberger
Nonsustained Ventricular Tachycardia in the Setting of Acute Myocardial Infarction : Tachycardia Characteristics and Their Prognostic Implications
Circulation, November 10, 1998; 98(19): 2030 - 2036.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Nolan, P. D. Batin, R. Andrews, S. J. Lindsay, P. Brooksby, M. Mullen, W. Baig, A. D. Flapan, A. Cowley, R. J. Prescott, et al.
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure : Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart)
Circulation, October 13, 1998; 98(15): 1510 - 1516.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. N. Singh, S. G. Fisher, P. E. Carson, R. D. Fletcher, and the Department of Veterans Affairs CHF STAT Invest
Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy
J. Am. Coll. Cardiol., October 1, 1998; 32(4): 942 - 947.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K PRASAD and M P FRENNEAUX
Hypertrophic cardiomyopathy: is there a role for amiodarone?
Heart, April 1, 1998; 79(4): 317 - 318.
[Full Text]


Home page
Journal Watch CardiologyHome page
Ventricular Tachycardia Predicts Sudden Death in CHF
Journal Watch Cardiology, January 27, 1997; 1997(127): 7 - 7.
[Full Text]